Protecting pharmaceutical and life-sciences data against a cyber-attack pandemic - Solution Brief

The COVID-19 pandemic has helped bring to the forefront another pandemic: cyber-attacks on pharmaceutical and life-sciences enterprises. Attempts to steal COVID-19 vaccine technology, clinical trial data sets, intellectual property, health records, and disrupt distribution supply chains have rattled the industry and national governments. It is one thing to have a credit card cloned, but it is much more serious when lives are at risk.